Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Tenpoint Therapeutics has raised $150.0M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2026.
Tenpoint Therapeutics's investors include British Business Bank, Hillhouse Investment, EQT, Janus Henderson Investors, Sofinnova Partners.
Tenpoint Therapeutics is headquartered in Camborne, United Kingdom.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Tenpoint Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tenpoint Therapeutics — Funding & Investors." VCBacked, January 28, 2026, https://www.vcbacked.co/company/tenpoint-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Tenpoint Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/tenpoint-therapeutics
{{cite web |title=Tenpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tenpoint-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated